Standard drugs from the pharmacy work differently for each person. Each person’s metabolism is too individual.
As Handelsblatt now reports, the startup Dihesys has set itself the goal of creating individual solutions here. In the future, medications are to be individually adapted from the active ingredient and digitally produced via a printer. Even multipreparations could be created in this way, improving the effects and therapy mechanisms and significantly reducing the number of drugs for the patient.
Read the full article: https://www.handelsblatt.com/unternehmen/industrie/gesundheitsversorgung-personalisierte-pillen-digital-gedruckte-medikamente-sollen-die-therapie-verbessern/28875788.html?utm_medium=social&utm_source=Xing&utm_campaign=koop&utm_content=ne&utm_term=organisch&xing_share=news